HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

AYFSVPLDKDFRKYT Pol(269-283) C*07:02 human epitope
 YFSVPLDEGFRKYTA Pol(270-284) human epitope
 YFSVPLDEGFRKYTA Pol(270-284) human epitope
 YFSVPLDEGFRKYTA Pol(270-284) human epitope
  FSVPLDEDFRKYTAFTIPSI Pol(271-290) human epitope
   SVPLDKDFRKYTAFTI Pol(272-287) human epitope
   SVPLDeDFRKYTAFTI Pol(272-287) non-susceptible form
    VPLDKDFRKYTAFTI Pol(273-287) C*07:02 human epitope
    VPLDKEFRKYTAFTIPSI Pol(273-290) human epitope
    VPLDKDFRKYTAFTIPSI Pol(273-290) human epitope
     PLDEGFRKYTAFTIP Pol(274-288) human epitope
     PLDEGFRKYTAFTIP Pol(274-288) human epitope
     PLDEGFRKYTAFTIP Pol(274-288) human epitope
         GFRKYTAFTIPSINN Pol(278-292) human epitope
         GFRKYTAFTIPSINN Pol(278-292) human epitope
         GFRKYTAFTIPSINN Pol(278-292) human epitope
            KYTAFTIPSI Pol(281-290) A*02:01 human epitope
            KYTAFTIPSI Pol(281-290) A2 human epitope
            KYTAFTIPSI Pol(281-290) human epitope
            KYTAFTIPSINNETP Pol(281-295) human epitope
            KYTAFTIPSINNETPGIR Pol(281-298) human epitope
             YTAFTIPSV Pol(282-290) A*02 human epitope
             YTAFTIPSI Pol(282-290) A*02 human epitope
             YTAFTIPSv Pol(282-290) observed variant
             YTAFTIPSI Pol(282-290) A*02 human epitope
             YTAFTIPSI Pol(282-290) A*02:01 human epitope
             YTAFTIPSI Pol(282-290) A*02:05 human epitope
             YTAFTIPSI Pol(282-290) A*02:06 human epitope
             YTAFTIPSI Pol(282-290) A*02:06 human epitope
             YTAFTIPSI Pol(282-290) A*02:06 human epitope
             YTAFTIPSI Pol(282-290) A*11 human epitope
             YTAFTIPSV Pol(282-290) A2 human epitope
             YTAFTIPSi Pol(282-290) diminished response
             YTAFTIPSI Pol(282-290) A2 human epitope
             YTAFTIPSI Pol(282-290) A2 human epitope
             YTAFTIPSI Pol(282-290) A2 human epitope
             YTAFTIPSI Pol(282-290) A2 human epitope
             YTAFTIPSV Pol(282-290) A2 human epitope
             YTAFTIPSI Pol(282-290) A2 human epitope
             YTAFTIPSI Pol(282-290) A2 human epitope
             YTAFTIPSV Pol(282-290) A2 human epitope
             YTAFTIPSI Pol(282-290) A2 supertype human epitope
             YTAFTIPSI Pol(282-290) A*66 human epitope
             YTAFTIPSI Pol(282-290) B*35:02, B*35:03, B*53:01 human epitope
             YTAFTIPSI Pol(282-290) B*51 human epitope
             YTAFTIPSI Pol(282-290) C*01 human epitope
             YTAFTIPSI Pol(282-290) human epitope
             YTAFTIPSINNETPG Pol(282-296) human epitope
             YTAFTIPSINNETPG Pol(282-296) human epitope
             YTAFTIPSINNETPG Pol(282-296) human epitope
              TAFTIPSI Pol(283-290) A*02:01 human epitope
              TAFTIPSI Pol(283-290) A*02:01, B*51:01 human epitope
              TAFTIPSI Pol(283-290) A*02:17, B*51:01 human epitope
              TAFTIPSI Pol(283-290) A*23 human epitope
              TAFTIPSI Pol(283-290) A*24 human epitope
              TAFTIPSI Pol(283-290) A*66 human epitope
              TAFTIPSI Pol(283-290) B*35:02, B*35:03, B*53:01 human epitope
              TAFTIPSI Pol(283-290) B*40 human epitope
              TAFTIPSI Pol(283-290) B*51 human epitope
              TAFTIPSt Pol(283-290) escape documented in this paper
              TAFTIPSI Pol(283-290) B*51 human epitope
              TAFTIPSI Pol(283-290) B*51 human epitope
              TAFTIPSt Pol(283-290) calculated escape
              TAFTIPSm Pol(283-290) observed variant
              TAFTIPSr Pol(283-290) observed variant
              TAFTvPSt Pol(283-290) observed variant
              TAFTIPSI Pol(283-290) B*51 human epitope
              TAFTIPSV Pol(283-290) B*51 human epitope
              TAFTIPSi Pol(283-290)
              TAFTIPSl Pol(283-290) diminished HLA binding or increased off-rate; susceptible form
              TAFTIPSt Pol(283-290) diminished HLA binding or increased off-rate
              TAFTIPSr Pol(283-290) non-susceptible form
              TAFTIPSI Pol(283-290) B*51 human epitope
              TAFTIPSI Pol(283-290) B*51 human epitope
              TAFTIPSI Pol(283-290) B*51 human epitope
              TAFTIPSl Pol(283-290) escape documented in this paper
              TAFTIPSv Pol(283-290) escape documented in this paper
              TAFTIPSt Pol(283-290) escape documented in this paper
              TAFTIPSr Pol(283-290) escape documented in this paper
              TAFTIPSI Pol(283-290) B*51 human epitope
              TAFTIPSt Pol(283-290) diminished HLA binding or increased off-rate
              TAFTIPSr Pol(283-290) diminished HLA binding or increased off-rate
              TAFTIPSI Pol(283-290) B*51, B*52 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSt Pol(283-290) susceptible form
              TAFTIPSv Pol(283-290) susceptible form
              TvFTIPSI Pol(283-290) non-susceptible form
              TAFTIPSt Pol(283-290) diminished response
              TAFTIPSv Pol(283-290) diminished response
              TvFTIPSt Pol(283-290) diminished response
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSt Pol(283-290) diminished response; susceptible form
              TAFTIPSm Pol(283-290) diminished response; susceptible form
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSt Pol(283-290) escape documented in this paper
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B51 human epitope
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSt Pol(283-290) diminished response
              TAFTIPSr Pol(283-290) diminished response
              TAFTIPSv Pol(283-290) diminished response
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSv Pol(283-290) escape documented in this paper
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSt Pol(283-290) diminished HLA binding or increased off-rate; escape documented in this paper
              TAFTIPSr Pol(283-290) diminished HLA binding or increased off-rate; escape documented in this paper
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSt Pol(283-290) diminished response; escape documented in this paper; non-susceptible form
              TAFTIPSv Pol(283-290) diminished response; escape documented in this paper; non-susceptible form
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSv Pol(283-290) diminished response
              TAFTIPSr Pol(283-290) diminished response
              TAFTIPSt Pol(283-290) diminished response
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSx Pol(283-290) escape documented in this paper
              TAFTIPSt Pol(283-290) calculated diminished HLA binding; observed variant
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSt Pol(283-290) diminished response
              TAFTIPSr Pol(283-290) diminished response
              TAFTIPSv Pol(283-290) diminished response
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSt Pol(283-290) escape documented in this paper
              TAFTIPSr Pol(283-290) escape documented in this paper
              TAFTIPSl Pol(283-290) escape documented in this paper
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TvFTIPSI Pol(283-290) observed variant
              TAFTIPSt Pol(283-290) observed variant
              TAFTIPSv Pol(283-290) observed variant
              TAFTIPSI Pol(283-290) B*51:01 human epitope
              TAFTIPSI Pol(283-290) B*51:01, B*52:01 human epitope
              TAFTIPSt Pol(283-290) observed variant
              TAFTIPSl Pol(283-290) observed variant
              TAFTIPSv Pol(283-290) observed variant
              TAFTIPSr Pol(283-290) observed variant
              TAFTIPSm Pol(283-290) observed variant
              TAFTIPSI Pol(283-290) B*52:01 human epitope
              TAFTIPSI Pol(283-290) C*12 human epitope
              TAFTIPSI Pol(283-290) human epitope
              TAFTIPSI Pol(283-290) human epitope
              TAFTIPSI Pol(283-290) human epitope
              TAFTIPSI Pol(283-290) human epitope
              TAFTIPSI Pol(283-290) human epitope
              TAFTIPSI Pol(283-290) human epitope
              TAFTIPSv Pol(283-290) escape documented in this paper; replicative capacity reduced; susceptible form
              TAFTvPSv Pol(283-290) escape documented in this paper; susceptible form
              TAFTIPSI Pol(283-290) human epitope
              TAFTIPSIN Pol(283-291) human epitope
                FTIPSINNETPGIRY Pol(285-299) A25 human epitope
                 TIPSINNETPGIRYQ Pol(286-300) human epitope
                 TIPSINNETPGIRYQ Pol(286-300) human epitope
                  IPSTNNETPG Pol(287-296) B7 human epitope
                   PSINNETPG Pol(288-296) human epitope
                    STNNETPGVRY Pol(289-299) B*18 human epitope
                    SINNETPGIRYQYNVLPQ Pol(289-306) human epitope
                     INNETPGIRYQYNVL Pol(290-304) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health